Latest News

Jan 9, 2018
Interim report Q3 2017 is available
Dec 20, 2017
Lytix Biopharma receives funding for innovation partnership with OncoImmunity in search for neoantigens
Dec 13, 2017
Dr Andrew Saunders has left Lytix Biopharma
Nov 8, 2017
Lytix Biopharma will present two posters at SITC in Washington

Meet the Management Team